About The Journal

Molecular Biomedicine is an English biomedical journal published by SpringerNature (https://www.springer.com/journal/43556), the largest open access (OA) publisher. The editor-in-chiefs of Molecular Biomedicine include Professor Arnold JM Driessen (member of the Royal Netherlands Academy of Arts and Sciences) from University of Groningen and Professor Wei Yuquan (member of the Chinese Academy of Sciences) from the State Key Laboratory of Biotherapy in West China Hospital of Sichuan University. Famous scientists from different countries make up the team of deputy editor-in-chiefs and editorial members.

Molecular Biomedicine is a peer-reviewed, online open access, multidisciplinary journal that publishes the pioneer works of biomedicine, emphasizing on pathogenic mechanism and innovative techniques for diagnosis and therapy. Molecular Biomedicine covers topics including but not limited to genetics/epigenetics, molecular biology, cell biology, bioinformatics, pharmacology, pharmacy, and clinical medicine. Molecular Biomedicine publishes a range of content types, including original research article, review, letter to the editor and research highlight, offering the latest advances in basic, translational and clinical research to meet the needs of academic readers in this field.

Molecular Biomedicine strives to become a high-quality SCI academic journal with international influence in biomedicine. The types of papers published in this journal include Research Articles, Reviews, Letters, and Research Highlights. It adopts a "quick passage" model for original achievements to help authors get their papers published quickly with a minimum time of only one week for review and acceptance. From 2020 to 2022, the article processing charge (APC) will be waived.